Lazarov v. Shaulov CA4/3

CourtCalifornia Court of Appeal
DecidedNovember 20, 2025
DocketG064739
StatusUnpublished

This text of Lazarov v. Shaulov CA4/3 (Lazarov v. Shaulov CA4/3) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lazarov v. Shaulov CA4/3, (Cal. Ct. App. 2025).

Opinion

Filed 11/20/25 Lazarov v. Shaulov CA4/3

NOT TO BE PUBLISHED IN OFFICIAL REPORTS

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FOURTH APPELLATE DISTRICT

DIVISION THREE

ALBENA IVANOVA HRISTOVA LAZAROV et al., G064739 Plaintiffs and Appellants, (Super. Ct. No. 30-2019-01118784) v. OPINION VITALIY SHAULOV, M.D.,

Defendant and Respondent.

Appeal from a postjudgment order of the Superior Court of Orange County, Thomas S. McConville, Judge. Affirmed. Request for judicial notice. Denied. Patricia A. Law & Associates and Patricia A. Law for Plaintiffs and Appellants. Walker Law Group, Jeffrey A. Walker and Laura L. Hummasti for Defendant and Respondent. * * * On October 9, 2018, Maxim Z. Lazarov, a husband and father, killed himself. The tragic suicide took place hours after he was discharged from the hospital where he was receiving psychiatric treatment after having attempted suicide only one week prior. Lazarov’s widow and son filed a professional negligence complaint against the medical professionals involved in Lazarov’s care leading up to his suicide. Among the defendants was Lazarov’s outpatient psychiatrist, Vitaliy Shaulov, M.D. The complaint alleged Dr. Shaulov “profound[ly]” mismanaged Lazarov’s medications in the months leading up to his suicide attempt. The complaint further alleged Dr. Shaulov’s substandard care and treatment of Lazarov was part of the cause of his initial suicide attempt, hospitalization, and eventual suicide, even though other doctors treated Lazarov during his hospitalization. Dr. Shaulov made offers to compromise under Code of Civil Procedure section 998 (section 998) four months after filing his answer to the complaint. The offers specified that both sides should agree to bear their own respective attorney fees and costs in exchange for a dismissal of the case. Plaintiffs rejected the offers as unreasonable. All defendants, except for Dr. Shaulov, had settled out of the case by the time of trial in 2024. The jury found Dr. Shaulov had not been negligent in his care of Lazarov. The trial court thereafter awarded Dr. Shaulov his costs, including expert witness fees pursuant to section 998. Plaintiffs argue Dr. Shaulov’s section 998 offers were not made in good faith, considering the circumstances of the case, his potential exposure,

2 and the stage of litigation during which they were served. We conclude plaintiffs failed to make the necessary showing of the unreasonableness of the offers under section 998, and therefore, the trial court did not abuse its discretion in denying the posttrial motion to strike or tax the expert costs. STATEMENT OF FACTS In March 2018, Lazarov presented to the hospital for the first time with suicidal thoughts. He was diagnosed with depression and hospitalized for one week. Dr. Shaulov began treating Lazarov in late May 2018 for anxiety and depression.1 Before May, Lazarov had seen another psychiatrist who had prescribed him numerous medications, including Cymbalta, Clonazepam, and Trazodone. Dr. Shaulov opted to continue these medications and added a prescription for Neurontin. Over the course of 10 subsequent visits between June 11 and September 25, 2018, Lazarov reported experiencing persistent and worsening anxiety, feelings of general unwellness, and dread. At each of these visits, Dr. Shaulov adjusted Lazarov’s existing medications, added new medications, or did both. On June 11, 2018, Dr. Shaulov discontinued the Neurontin prescription and added Rexulti. On June 25, he discontinued the Rexulti and increased the Cymbalta dosage. On July 11, he added Effexor and

We have gleaned many of the facts pertinent to Lazarov’s 1

medical condition and treatment from the declaration submitted to the court by Dr. Shaulov’s psychiatric expert, Stephen M. Stahl, M.D., Ph.D., in opposition to plaintiffs’ motion to strike or tax costs. Dr. Stahl averred he had reviewed Lazarov’s medical records to render his opinion at trial. No declaration from plaintiffs’ psychiatric expert appears in the appellate record.

3 Fludrocortisone. When Lazarov reported he had seen no improvement from the new medication, on July 17, Dr. Shaulov increased his Effexor dosage. On July 25, he added Abilify to Lazarov’s regimen. On July 31, Lazarov told Dr. Shaulov that his symptoms were getting worse and he wished to taper off his use of antidepressants. Dr. Shaulov decreased Lazarov’s Effexor dose, discontinued the Abilify (which Lazarov had not yet begun to take), and added Lunesta. Lazarov’s nervousness increased as he began to taper off the antidepressants. On August 6, Dr. Shaulov prescribed Propranolol and Lithium Orotate for anxiety, and iodine to slow down Lazarov’s thyroid. At his August 16 visit, Lazarov reported that he had unilaterally taken himself off Effexor and Cymbalta and was experiencing constant obsessive thoughts. Dr. Shaulov prescribed Abilify and Benadryl. After Lazarov’s anxiety increased, Dr. Shaulov discontinued Abilify on September 12 and increased the Clonazepam dosage. Lazarov’s last appointment with Dr. Shaulov was on September 25, 2018. There was no change in his condition. Dr. Shaulov added Latuda to the medication regimen. He never saw Lazarov again. One week later, on October 2, 2018, Lazarov presented to the emergency department at Mission Hospital Regional Medical Center in Mission Viejo. He was in crisis and had attempted suicide. He was hospitalized under the care of a different set of doctors and then discharged on October 9. Dr. Shaulov was not consulted on Lazarov’s treatment during this period. Lazarov killed himself the day he was released. PROCEDURAL HISTORY On December 17, 2019, Lazarov’s widow, Albena Lazarov, and son, Maxim Lazarov, Jr. (plaintiffs), filed their lawsuit. Dr. Shaulov filed his

4 answer to the complaint in March 2020. In July 2020, four and a half months later, Dr. Shaulov’s counsel served section 998 offers on plaintiffs. The terms of the offers were: dismissal with prejudice of all claims by plaintiffs; execution of a general release by plaintiffs in favor of Dr. Shaulov; and the parties would bear their own costs and attorney fees. Plaintiffs served objections to the section 998 offers on August 6, 2020. Citing Wear v. Calderon (1981) 121 Cal.App.3d 818, 821 (Wear), the objections stated the offers were “not realistically reasonable under the circumstances of the case” and they had “no chance of being accepted.” The objections did not alert Dr. Shaulov that plaintiffs lacked sufficient information to evaluate the offers. At the time the offers were served, plaintiffs had served discovery responses showing they were claiming over $168,000 in annual lost income from Lazarov’s death. No depositions had yet been taken, although plaintiffs had noticed Dr. Shaulov’s deposition for June and then again for August.2 His deposition finally took place in September 2020, after the offers had expired. Dr. Shaulov filed a motion for summary judgment two weeks before service of his 998 offers. The trial court ultimately denied the motion because the declaration provided by plaintiffs’ expert created a triable issue of material fact as to whether Dr. Shaulov complied with the applicable standard of care or contributed to plaintiffs’ damages. The jury trial was originally scheduled for September 2021, but trial did not actually commence until January 3, 2024. By a vote of 10 to 2,

2 Plaintiffs ask us to take judicial notice of the closure orders issued by the Governor and state and county public health officials during the COVID-19 pandemic.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wear v. Calderon
121 Cal. App. 3d 818 (California Court of Appeal, 1981)
Clark v. Optical Coating Laboratory, Inc.
165 Cal. App. 4th 150 (California Court of Appeal, 2008)
Whatley-Miller v. Cooper
212 Cal. App. 4th 1103 (California Court of Appeal, 2013)
Licudine v. Cedars-Sinai Med. Ctr.
242 Cal. Rptr. 3d 76 (California Court of Appeals, 5th District, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Lazarov v. Shaulov CA4/3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lazarov-v-shaulov-ca43-calctapp-2025.